// App-Quantinova.ai

P813 : EFFICACY, TREATMENT ADMINISTRATION SATISFACTION AND SAFETY OF SUBCUTANEOUS RAVULIZUMAB THROUGH 1 YEAR IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO RECEIVED PRIOR INTRAVENOUS ECULIZUMAB

Researchers

Presenter

  • Mustafa N. Yenerel

Principal Investigators

  • Flore Sicre de Fontbrune

  • Caroline Piatek

  • Fahri Sahin

  • Wolfgang Freder

  • Masayo Ogawa

  • Ioannis Tomazos

  • Helen Doll

  • Ayca Ozol-Godfrey

  • J. Rafael Sierra

  • Jeff Szer

Medical Centers

  • Clinical Outcomes Solutions, Folkestone, United Kingdom

  • Jane Anne Nohl Division of Hematology,Keck School of Medicine of University of Southern California,Los Angeles,United States

  • Division of Hematology and Hemostaseology, Medical University of Vienna, Wien, Austria

  • Division of Hematology, Departm

  • Alexion, AstraZeneca Rare Disease,Boston, MA,Estados Unidos

  • Department of Hematology,Ege University Bornova,Izmir,Turkey

  • Clinical Outcomes Solutions,Folkstone,Verenigd Koninkrijk

  • Department of Hematology,

  • Division of Hematology and Hemostaseology, Medical University of Vienna, Wien, Austria

  • Alexion, AstraZeneca Rare Disease,Boston,

  • Department of Hematology,Ege University Bornova,Izmir,Turkey

  • Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital,Melbourne, VIC,Australie

  • Hematology and Bone Marrow Transplant Unit,Assistance Publique Hôpitaux des Paris, Saint Louis Hospital,Paris,France

  • Alexion, AstraZeneca Rare Disease,Boston, MA,Verenigde Staten

  • Hematology and Bone Marrow Transplant Unit,Assistance Publique Hôpitaux des Paris, Saint Louis Hospital,Paris,France

  • Clinical Outcomes Solutions,

  • Department of Hematology,Ege University Bornova,Izmir,Turkey

  • Clinical Outcomes Solutions,Folkstone,Regno Unito

  • Alexion, AstraZeneca Rare Disease,Boston, MA,Verenigde Staten

  • Department of Hematology,Ege University Bornova,Izmir,Turkey

  • Division of Endocrinology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

  • Hematology and Bone Marrow Transplant Unit,Ospedale

  • Clinical Outcomes Solutions,Folkstone,Regno Unito

  • Division of Endocrinology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

  • Department of Hematology,Ege University Bornova,Izmir,Turkey

  • Division of Hematology and Hemostaseology,Medical Un

  • Alexion, AstraZeneca Rare Disease,Boston, MA,Estados Unidos

  • Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital,Melbourne, VIC,Australie

  • Department of Hematology,Ege University Bornova,Izmir,Turkey

  • Clinical Outcomes Solutions,Folkstone,Verenigd Koninkrijk

  • Division of Endocrinology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

  • Hematology and Bone Marrow Transplant Unit,Assistance Publique Hôpitaux des Paris, Saint Louis Hospital,Paris,France

  • Clinical Outcomes Solutions,Folkstone,Royaume-uni

  • Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia

  • Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA

  • Division of Hematology and Hemostaseology, Medical University of Vienna, Wien, Austria

  • Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA

  • Alexion, AstraZeneca Rare Disease,Boston, MA,Estados Unidos

  • Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital,Melbourne, V

  • Jane Anne Nohl Divi

  • Alexion, AstraZeneca Rare Disease,Boston, MA,United States

Locations

  • France

  • United States

  • Turkey

  • Austria

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Paroxysmal nocturnal hemoglobinuria

Biomarkers

  • Lactate dehydrogenase

Drug/Treatment

  • Eculizumab

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • N/A

Study Id's

  • NCT02946463

  • NCT03056040

  • NCT03406507

  • NCT03748823

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved